INHIBIDORES CONTRA EL FACTOR VIII DE COAGULACIÓN EN LA HEMOFILIA TIPO A Coagulation Factor VIII Inhibitors in hemophilia type A +Carlos A. Medina *Rhina Z. Pineda RESUMEN /RVLQKLELGRUHVVRQXQSUREOHPDJUDYHTXHSXHGH RFXUULUFXDQGRXQDSHUVRQDFRQKHPRÀOLDSUHVHQWD XQD UHVSXHVWD LQPXQROyJLFD DO WUDWDPLHQWR FRQ FRQFHQWUDGRV GH IDFWRU 9,,, GH FRDJXODFLyQ (O VLVWHPD LQPXQROyJLFR SURWHJH DO FXHUSR FRQWUD JpUPHQHV \ YLUXV GDxLQRV SHUR DOJXQDV YHFHV HO VLVWHPDLQPXQROyJLFRGHXQDSHUVRQDUHDFFLRQDD ODV SURWHtQDV GH ORV FRQFHQWUDGRV GH IDFWRU FRPR VL IXHUDQ VXVWDQFLDV DMHQDV \D TXH HO FXHUSR QR ODV UHFRQRFH &XDQGR HVWR RFXUUH VH IRUPDQ LQKLELGRUHV WDPELpQ OODPDGRV DQWLFXHUSRV HQ OD VDQJUH SDUD DWDFDU D ODV SURWHtQDV GH IDFWRU 9,,, (VWRLPSLGHDORVFRQFHQWUDGRVGHIDFWRUFRUUHJLU HOSUREOHPDKHPRUUiJLFR Palabras Clave: +HPRÀOLD VHYHUD WLSR $ WROHUDQFLDDOIDFWRU9,,,FRPSLODFLyQHQKHPRÀOLD WLSR$ ABSTRACT 3DWLHQWZLWK7\SH$+HPRSKLOLDSUHVHQWLQKLELWRUV ZKLFK DUH VHULRXV PHGLFDO SUREOHPV ZKHQ WKH\ UHDFW LQ DQ LPPXQRORJLFDO UHVSRQVH WR WUHDWPHQW ZLWK FRDJXODWLRQ FRQFHQWUDWLRQV RI )DFWRU 9,,, 7KH ,PPXQH 6\VWHP SURWHFWV WKH ERG\ DJDLQVW JHUPV YLUXVHV DQG PDQ\ RWKHU IRUHLJQ DJHQWV +HPRSKLOLDFVGHYHORSDQLPPXQRORJLFDOUHVSRQVH LQYROYLQJ WKH VHFUHWLRQ RI LQKLELWRUV DOVR NQRZQ DV DQWLERGLHV LQWR WKH EORRG ZKLFK LQKLELWV FRDJXODWLRQ IURP )DFWRU 9,,, SURWHLQ WKLV GXH ”Mario A. Rush, José Reyes WR WKH IDFW WKDW WKH ERG\ GRHV QRW UHFRJQL]H WKLV SURWHLQ7KHGHYHORSPHQWRIWKHVHHYHQWVSUHYHQWV WKH )DFWRU 9,,, FRQFHQWUDWLRQV WR FRUUHFW WKH KHPRUUKDJLFSUREOHP Key Words: 6HYHUH W\SH $ KHPRSKLOLD WROHUDQFHWRIDFWRU9,,,FRPSOLFDWLRQVLQW\SH$ KHPRSKLOLD CASO CLÍNICO 3DFLHQWH PDVFXOLQR GH DxRV FRQ KLVWRULD GH KHPRÀOLD GLDJQRVWLFDGD DO PHV GH QDFLGR SUHVHQWDQGR FXDGURV UHSHWLGRV GH KHPRUUDJLD HQ ODV DUWLFXODFLRQHV PD\RUHV SULQFLSDOPHQWH D QLYHOGHODVURGLOODV\ORVFRGRVODVFXDOHVIXHURQ GHIRUPDQGR SURJUHVLYDPHQWH VXV H[WUHPLGDGHV H LQFDSDFLWDQGRHOPRYLPLHQWRItVLFR&RQWURODGDFRQ )DFWRU9,,,UHFRPELQDQWHGXUDQWHDxRV+DFH DxRVVHREVHUYyTXH\DQRUHVSRQGtDDODUHVWLWXFLyQ GHOIDFWRUHQODVGRVLVWHUDSpXWLFDV\SUHVHQWyXQD FULVLV GH DQDÀOD[LD GHVSXpV GH OD DSOLFDFLyQ GH VX WUDWDPLHQWR KDELWXDO 6H OH UHDOL]DURQ DQiOLVLV GH%HWKHVGDORVFXDOHVUHSRUWDURQODSUHVHQFLDGH LQKLELGRUHV FRQWUD )DFWRU 9,,, VLHQGR WUDWDGR D SDUWLUGHHQWRQFHVFRQIDFWRU9,,DUHFRPELQDQWHHO FXDOQRPHMRUyVXFRQGLFLyQGHVDOXG $ SDUWLU GH HQWRQFHV HO SDFLHQWH UHÀHUH XQD GLVPLQXFLyQGHODFDOLGDGGHYLGD\DTXHODPD\RU SDUWH GH VX WLHPSR SDVD LQWHUQR HQ HO +RVSLWDO (VFXHOD SRU SUHVHQWDU KHPRUUDJLDV PDVLYDV \ HVSRQWiQHDV HVSHFLDOPHQWH HQ URGLOODV FRGRV \ KRPEURVDFRPSDxDGDGHGRORULQFDSDFLWDQWH+DFH + Gineco-Obstetra, Profesor Titular IV, Facultad de Ciencias Médicas de la UNAH. * Estudiante de VI año, Carrera de Medicina de la UNAH. Miembro de ASOCEMH-UNAH. ” Estudiantes de III año, Carrera de Medicina de la UNAH. Miembros de ASOCEMH-UNAH Rev. Fac. Cienc. Méd. Julio - Diciembre 2010 Inhibidores Contra el Factor VIII de Coagulación en la Hemofilia Tipo A XQDxRSUHVHQWDFHIDOHDKRORHQFHIiOLFDFRQWLQXDGH WLSRSXOViWLOGHSUHGRPLQLRPDWXWLQRUHDOL]iQGRVHOH XQD 7RPRJUDItD$[LDO &RPSXWDUL]DGD 7$& TXH PRVWUyODSUHVHQFLDGHP~OWLSOHVPLFURLQIDUWRVHQ HOOyEXORRFFLSLWDOL]TXLHUGRGHOFHUHEUR /RVQLYHOHVGH7LHPSRGH7URPERSODVWLQD3DUFLDO 773 SHUPDQHFHQ HOHYDGRV DXQ GHVSXpV GH OD DSOLFDFLyQGHO)DFWRU9,,DUHFRPELQDQWH Antecedentes familiares patológicos:+HUPDQR PHQRU FRQ GLDJQyVWLFR GH KHPRÀOLD PXULy SRU KHPRUUDJLDPDVLYDXQVREULQRKHPRItOLFRPXULy SRU DSHQGLFLWLV FRPSOLFDGD DPERV FDVRV VLQ DQWHFHGHQWHV GH KDEHU GHVDUUROODGR LQKLELGRUHV 1LHJD FDVRV IDPLOLDUHV GH KHPRÀOLD SUHFHGLGRV D pO KDEHUVLGR´YLVWDµDQWHVSRUHOVLVWHPDLQPXQH\ SODQWHDXQUHWRWHUDSpXWLFRPX\GLItFLOGHVXSHUDU (O GHVDUUROOR GH LQKLELGRUHV UHSUHVHQWD OD FRPSOLFDFLyQ PiV VHYHUD HQ HO WUDWDPLHQWR GHO HQIHUPRKHPRItOLFR /DV KHPRUUDJLDV VRQ PX\ GLItFLOHV GH FRQWURODU HQ XQD SHUVRQD FRQ KHPRÀOLD TXH SUHVHQWD LQKLELGRUHV8QDSHUVRQDFRQLQKLELGRUHVHQIUHQWD PiV KHPRUUDJLDV \ GRORU SRUTXH HO WUDWDPLHQWR FRQ FRQFHQWUDFLRQHV GH IDFWRU QR IXQFLRQD 6t OD KHPRUUDJLD HQ P~VFXORV \ DUWLFXODFLRQHV QR HV FRQWURODGDHVSUREDEOHTXHKD\DGDxRVDUWLFXODUHV (O GHVDUUROOR GH DQWLFXHUSRV LQKLELGRUHV FRQGLFLRQDQRVyORXQDGLVPLQXFLyQGHODFDOLGDG GHYLGDGHORVSDFLHQWHVVLQRTXHWDPELpQWLHQHQ LPSRUWDQWHVFRQVHFXHQFLDVVRFLRHFRQyPLFDVGDGR HOLQFUHPHQWRHQHOFRVWRGHOWUDWDPLHQWR INTRODUCCIÓN /D +HPRÀOLD $ HV XQD HQIHUPHGDG KHUHGLWDULD DVRFLDGD FRQ KHPRUUDJLDV JUDYHV HVSRQWiQHDV R SURYRFDGDV6HGHEHDXQDUHGXFFLyQHQODFDQWLGDGR DODDFWLYLGDGGH)DFWRU9,,,/DKHPRÀOLDVHKHUHGD FRQFDUiFWHUUHFHVLYROLJDGRDOFURPRVRPD;ORV VXMHWRVPDVFXOLQRVVRQORVDIHFWDGRVFOtQLFDPHQWH SRUTXHODVPXMHUHVVRQSRUWDGRUDVGHOJHQPXWDGR SRUORJHQHUDOVRQDVLQWRPiWLFDV$IHFWDDGHFDGD YDURQHVHQWRGRHOPXQGR $SUR[LPDGDPHQWH HO GH ORV SDFLHQWHV QR WLHQHQKLVWRULDIDPLOLDUVXHQIHUPHGDGHVWiFDXVDGD SRVLEOHPHQWH SRU PXWDFLRQHV QXHYDV /D KHPRÀOLD$ H[KLEH XQD DPSOLD JDPD GH YDULHGDG FOtQLFDODJUDYHGDGGHpVWDGHSHQGHGHODFDQWLGDG GHIDFWRUGHFRDJXODFLyQTXHIDOWDHQODVDQJUHGH XQDSHUVRQD/RVLQGLYLGXRVFRQPHQRVGHGH ODDFWLYLGDGQRUPDOGHVDUUROODQHQIHUPHGDGJUDYH ORVQLYHOHVHQWUH\VHDVRFLDQFRQHQIHUPHGDG PRGHUDGD\ORVQLYHOHVHQWUH\GHDFWLYLGDG H[SHULPHQWDQHQIHUPHGDGOHYH$OUHGHGRUGHO GH ORV SDFLHQWHV FRQ )DFWRU 9,,, EDMR R DXVHQWH GHVDUUROODQ DQWLFXHUSRV LQKLELGRUHV TXH VH XQHQ DOIDFWRU9,,,\ORLQKLEHQSRVLEOHPHQWHGHELGRD TXH OD SURWHtQD HV SHUFLELGD FRPR H[WUDxD DO QR Epidemiologia 'H DFXHUGR FRQ OD )HGHUDFLyQ 0XQGLDO GH OD +HPRÀOLDHQHODxRKDEtDSDFLHQWHV FRQ KHPRÀOLD UHJLVWUDGRV 6H HVWLPD TXH HQWUH \ SDFLHQWHV KHPRItOLFRV HQ /DWLQR $PpULFD WLHQHQ LQKLELGRUHV (O GHVDUUROOR GH LQKLELGRUHVVXFHGHHQXQ²GHORVSDFLHQWHV FRQKHPRÀOLD$ 8QDPD\RULQFLGHQFLDGH+HPRÀOLD$VHSUHVHQWD HQSDFLHQWHVFRQXQKLVWRULDOIDPLOLDUGHDQWLFXHUSRV FRQWUDHO)DFWRU9,,,/DVSHUVRQDVGHDVFHQGHQFLD DIULFDQDFRQ+HPRÀOLD$WLHQHQPiVSRVLELOLGDGHV GHGHVDUUROODULQKLELGRUHVGHO)DFWRU9,,,TXHODV SHUVRQDVFDXFiVLFDV Etiología (Q UHODFLyQ FRQ OD HWLRSDWRJHQLD PXFKR VH KD HVSHFXODGR DFHUFD GH FXiOHV VRQ ODV FDXVDV TXH FRQGLFLRQDQ OD DSDULFLyQ GH DQWLFXHUSRV LQKLELGRUHV 6H KDQ LPSOLFDGR IDFWRUHV JHQpWLFRV IXQGDPHQWDOPHQWH UHODFLRQDGRV FRQ HO WLSR GHDOWHUDFLyQJHQpWLFDTXHFRQGLFLRQDODKHPRÀOLD HOVLVWHPD$QWtJHQR+XPDQR/HXFRFLWDULR+/$ \ HO WLSR GH IDFWRU XWLOL]DGR HQ OD WHUDSpXWLFD VXVWLWXWLYD /RV SDFLHQWHV TXH VH VRPHWHQ D Rev. Fac. Cienc. Méd. Julio - Diciembre 2010 Inhibidores Contra el Factor VIII de Coagulación en la Hemofilia Tipo A OD WHUDSLD GH UHHPSOD]DPLHQWR HQ XQ SURGXFHQDQWLFXHUSRVQHXWUDOL]DQWHV(OSDSHO GHVHPSHxDGR SRU HO VLVWHPD LQPXQH D OD KRUD GH GHVDUUROODUDQWLFXHUSRVHVIXQGDPHQWDOQRVyORSRU UHJXODUORVIHQyPHQRVGHWROHUDQFLDLQPXQHIUHQWH DO )DFWRU 9,,, VLQR SRU FRQIRUPDU OD PDTXLQDULD HIHFWRUD GHO RUJDQLVPR GHÀFLHQWH GH IDFWRU IUHQWH ODDGPLQLVWUDFLyQH[yJHQDGHSURWHtQD Fisiopatología Respuesta inmune al Factor VIII (Q OD KHPRÀOLD FXDQGR QR HVWi OD SURWHtQD GHO )DFWRU 9,,, SDUD FUHDU WROHUDQFLD OD LQIXVLyQ GH FRQFHQWUDGRV GH )9,,, JHQHUD OD UHVSXHVWD LQPXQLWDULD OD FXDO VH LQLFLD GHVGH ODV FpOXODV SUHVHQWDGRUDVGHDQWtJHQR&3$TXHLQWHUDFW~DFRQ ORVOLQIRFLWRV7\HVWRVDVXYH]FRQORVOLQIRFLWRV % (VWRV ~OWLPRV KDQ XQLGR \ HQGRFLWDGR ORV DQWtJHQRVSURWHLFR\SRVWHULRUPHQWHSUHVHQWDQORV SpSWLGRVGHULYDGRVGHHVWHDQWtJHQRDORVOLQIRFLWRV 7 FRRSHUDGRUHV \ D OD YH] HVWRV HVWLPXODQ D ORV OLQIRFLWRV%SDUDTXHVLQWHWLFHQDQWLFXHUSRVIUHQWH D HVD SURWHtQD ([LVWHQ PXFKDV HYLGHQFLDV TXH FRQÀUPDQ TXH DO LJXDO TXH HQ OD PD\RUtD GH ORV DQWtJHQRV SURWHLFRV OD UHVSXHVWD KXPRUDO TXH VH SURGXFH IUHQWH DO )DFWRU 9,,, HV OLQIRFLWR 7 GHSHQGLHQWH /DUHVSXHVWDLQPXQHIUHQWHDXQDQWtJHQRSHSWtGLFR H[WUDFHOXODUFRPRHVHO)DFWRU9,,,RFXUUHDWUDYpV GH XQD VHULH GH LQWHUDFFLRQHV HQWUH ODV FpOXODV SUHVHQWDGRUDV GH DQWtJHQD &3$ ORV OLQIRFLWRV7 &'\ORVOLQIRFLWRV% (O HYHQWR LQLFLDO HQ HVWD FDVFDGD FHOXODU HV HO FRQWDFWRHQWUHHO)DFWRU9,,,\ODV&3$7UDVHVWD XQLyQ VH SURGXFH XQD HQGRFLWRVLV GHO )DFWRU9,,, D WUDYpV GH YHVtFXODV SURGXFLpQGRVH OD XQLyQ GH GHWHUPLQDGDVVHFXHQFLDVSHSWtGLFDVGHO)DFWRU9,,, FRQPROpFXODVGHFODVH,,GHOFRPSOHMRPD\RUGH KLVWRFRPSDWLELOLGDG&0+/DXQLyQGHSpSWLGRV SURFHGHQWHVGHO)DFWRU9,,,DPROpFXODVGHFODVH,, GHO&0+HVHVSHFLÀFRGHODVHFXHQFLDSHSWtGLFD\ GHSHQGLHQWHGHODLQWHUDFFLyQHQWUHORVDPLQRiFLGRV GHO)DFWRU9,,,\ORVDPLQRiFLGRVTXHFRQIRUPDQ OD ]RQD GH XQLyQ D SpSWLGRV GH ODV PROpFXODV GH FODVH,,GHO&0+ (O UHFRQRFLPLHQWR GH HVWH FRPSOHMR IRUPDGR SRU DQWtJHQRV SHSWtGLFRV GHO )9,,, \ PROpFXODV FODVH ,, GHO &0+ VH UHDOL]D D WUDYpV GHO UHFHSWRU GH OLQIRFLWRV 7 7&5 \ &' (VWD XQLyQ GHO UHFHSWRU DO DQWtJHQR QR HV FDSD] GH SURGXFLU DFWLYDFLyQ OLQIRFLWDULD GH IRUPD DLVODGD VLQR TXH QHFHVLWD GH OD SDUWLFLSDFLyQ GH ODV GHQRPLQDGDV YtDV FRHVWLPXODGRUDV %iVLFDPHQWH HVWDV YtDV FRQVWLWX\HQFRPSOHMRVOLJDQGR²UHFHSWRUQHFHVDULRV SDUDODDFWLYDFLyQ\UHJXODFLyQOLQIRFLWDULD )LQDOPHQWH GH OD LQWHUDFFLyQ GH WRGDV ODV VXE SREODFLRQHVOLQIRFLWDULDVVHFRQVLJXHODSURGXFFLyQ GH DQWLFXHUSRV IUHQWH DO )DFWRU 9,,, JUDFLDV D OD GLIHUHQFLDFLyQ ÀQDO GH ORV OLQIRFLWRV % D FpOXODV SODVPiWLFDV ODV FXDOHV DGTXLHUHQ OD FDSDFLGDG GH SURGXFLU \ VHFUHWDU JUDQGHV FDQWLGDGHV GH DQWLFXHUSR (VWRV DQWLFXHUSRV LQKLELWRULRV IUHQWH DO IDFWRU 9,,, VRQ GH FDUDFWHUtVWLFDV SROLFORQDOHV JHQHUDOPHQWH,J*\HQDOJXQRVFDVRV,J* Aspectos generales de los inhibidores 8QLQKLELGRUHVXQWLSRGHDQWLFXHUSR/DIXQFLyQGH ORVDQWLFXHUSRVHQHORUJDQLVPRHVWUDWDUGHGHVWUXLU VXVWDQFLDVTXHQRUHFRQRFHQ(ORUJDQLVPRGHXQD SHUVRQD FRQ +HPRÀOLD$ SXHGH FUHDU LQKLELGRUHV GLULJLGRV FRQWUD HO )DFWRU 9,,, GHVSXpV GH OD DGPLQLVWUDFLyQGHOWUDWDPLHQWRSDUDUHHPSOD]DUHO IDFWRUFDUHQWH(OGHODVSHUVRQDTXHSUHVHQWDQ LQKLELGRUHV OR KDFHQ GHQWUR GH ODV SULPHUDV H[SRVLFLRQHVDORVFRQFHQWUDGRVGHIDFWRU VLHQGR HO PRPHQWR GH PD\RU ULHVJR HO SHULRGR HQWUH ORV SULPHURV\WUDWDPLHQWRV(VWRTXLHUHGHFLU TXH ORV LQKLELGRUHV VH SUHVHQWDQ SULQFLSDOPHQWH HQ QLxRV FRQ KHPRÀOLD VHYHUD DXQTXH WDPELpQ SXHGHQ SUHVHQWDUVH HQ HWDSDV SRVWHULRUHV GH OD YLGDHQSHUVRQDVFRQKHPRÀOLDOHYHRPRGHUDGD GHVSXpVGHUHFLELUWUDWDPLHQWR (VWDFRPSOLFDFLyQVHSUHVHQWDFRQPD\RUIUHFXHQFLD HQSDFLHQWHVFRQKHPRÀOLDJUDYHTXHHQSHUVRQDV FRQKHPRÀOLDOHYHRPRGHUDGD\HVPiVFRP~QHQ Rev. Fac. Cienc. Méd. Julio - Diciembre 2010 Inhibidores Contra el Factor VIII de Coagulación en la Hemofilia Tipo A OD+HPRÀOLD$DTXHHQODKHPRÀOLD% (O DQWLFXHUSR VH DGKLHUH DO )DFWRU 9,,, \ OR QHXWUDOL]DRLQKLEHVXFDSDFLGDGSDUDGHWHQHUXQD KHPRUUDJLD &XDQGR VH GHWHFWD XQ DQWLFXHUSR SRU OR JHQHUDO VH FODVLÀFD FRPR GH ´DOWD R EDMD UHVSXHVWDµ GHSHQGLHQGR GH OD IRUPD HQ OD TXH HVWLPXOHDOVLVWHPDLQPXQHGHXQDSHUVRQDGHVSXpV GHUHSHWLGDVH[SRVLFLRQHVDO)DFWRU9,,, (Q OD +HPRÀOLD$ ORV SDFLHQWHV FRQ PXWDFLRQHV TXH WUXQFDQ R LPSLGHQ OD SURGXFFLyQ GHO )DFWRU 9,,, LQYHUVLyQ GH LQWUyQ GHOHFLRQHV JUDQGHV PXWDFLRQHVVLQVHQWLGRWLHQHQPD\RUIUHFXHQFLDGH GHVDUUROODULQKLELGRUHVTXHDTXHOORVFRQGHOHFLRQHV Sintomatología en una persona que ha desarrollado inhibidores 6HVRVSHFKDODSUHVHQFLDGHLQKLELGRUHVFXDQGROD SHUVRQDHOIDPLOLDURHOSHUVRQDOPpGLFRQRWDQTXH HOWUDWDPLHQWRHVPHQRVHÀFD]GHORTXHVROtDVHU +DOOD]JRVFOtQLFRV /DKHPRUUDJLDQRVHFRQWURODDGHFXDGDPHQWH FRQODGRVLVXVXDOGHFRQFHQWUDGRVGHIDFWRU (O WUDWDPLHQWR QRUPDO SDUHFH VHU FDGD YH] PHQRVHÀFD] /D KHPRUUDJLD HV FDGD YH] PiV GLItFLO GH FRQWURODU \D TXH XQD SHUVRQD FRQ KHPRÀOLD TXH KD GHVDUUROODGR LQKLELGRUHV QR PHMRUDUiGHVSXpVGHOWUDWDPLHQWRQRUPDOFRQ FRQFHQWUDGRVGHIDFWRU Diagnóstico &RQ IUHFXHQFLD VH VRVSHFKD OD SUHVHQFLD GH LQKLELGRUHVGXUDQWHXQDSUXHEDGHVDQJUHGHUXWLQD FRQRFLGDFRPRHQVD\RGHWLHPSRGHWURPERSODVWLQD SDUFLDODFWLYDGR773D/DSUXHEDGH773DPLGH HOWLHPSRTXHWDUGDODVDQJUHHQFRDJXODU&XDQGR KD\ LQKLELGRUHV SUHVHQWHV OD VDQJUH WDUGD HQ FRDJXODURQRFRDJXODFRPSOHWDPHQWHDXQGHVSXpV GHKDEHUVHPH]FODGRFRQSODVPDQRUPDO (Q XQ SDFLHQWH FRQ GLDJQyVWLFR GH KHPRÀOLD TXH QRUHVSRQGHDOWUDWDPLHQWRVXVWLWXWLYRFRQODVGRVLV DGHFXDGDV VH UHDOL]DQ ORV VLJXLHQWHV PpWRGRV GH GHWHFFLyQGHLQKLELGRUHV 'HWHUPLQDFLyQSRUXQLGDGHV2[IRUG 3UXHEDVFOiVLFDVGH%HWKHVGD 'HWHUPLQDFLyQGH1LMPHJHQ 7HFLQDVGH(OLVD (O HQVD\R %HWKHVGD HV HO PpWRGR HVWiQGDU UHFRPHQGDGR SDUD OD PHGLFLyQ GH ORV WtWXORV GH LQKLELGRUHVGHO)9,,, Con la prueba de Bethesda los inhibidores se clasifican en: /RV GH EDMD UHVSXHVWD SRVHHQ QLYHOHV GH LQKLELGRUHV D 8QLGDGHV %HWKHVGD PO %8 1R GHVDUUROODQ XQ LQFUHPHQWR HQ ORV QLYHOHV GH LQKLELGRUHVOXHJRGHVXEVLJXLHQWHVH[SRVLFLRQHVD )9,,, /RVGHDOWDUHVSXHVWDSRVHHQWtWXORVGHLQKLELGRUHV !%8PORELHQVLORVQLYHOHVKDEtDQGHVFHQGLGR EDMRHVWDFLIUDORVWtWXORVVXELUtDQD!%8PO OXHJRGHODUHH[SRVLFLyQD)9,,, Tratamiento (O HVWXGLR GH OD SUHVHQFLD GHO LQKLELGRU FRQWUD OD PROpFXOD GHO IDFWRU 9,,, FRQVWLWX\H RWUR GH ORV DYDQFHV HQ HO WUDWDPLHQWR GH ODV SHUVRQDV FRQ KHPRÀOLDTXHKDQGHVDUUROODGRLQKLELGRUHVFRQWUD IDFWRU9,,, Tratamiento de sangrado leve y moderado en pacientes con hemofilia A e inhibidores de baja respuesta: $OWDV 'RVLV GH )9,,, GH ² ,8NJ GH SHVR FRUSRUDOHQERORFDGDDKRUDV6LQRKXELHUH UHVSXHVWD D ODV DOWDV GRVLV GH )9,,, VDQJUDGR SHUVLVWHQWH GHELGR D LPSRVLELOLGDG GH PDQWHQHU QLYHOHV DGHFXDGRV GH )9,,, $XPHQWDU GRVLV DQWHULRU R FDPELDU DO WUDWDPLHQWR SDUD SDFLHQWHV FRQDOWDUHVSXHVWD Rev. Fac. Cienc. Méd. Julio - Diciembre 2010 Inhibidores Contra el Factor VIII de Coagulación en la Hemofilia Tipo A Tratamiento de sangrado leve y moderado en pacientes con hemofilia A e inhibidores de alta respuesta 6H XWLOL]D IDFWRU 9,, DFWLYDGR UHFRPELQDGR U)9,,D \ HO FRQFHQWUDGR GH FRPSOHMR GH SURWURPELQD DFWLYDGR D3&& FRQVWLWX\HQ ORV DJHQWHVSUHIHULGRVSDUDHOVDQJUDGROHYH\PRGHUDGR HQSDFLHQWHVGHDOWDUHVSXHVWD (O IDFWRU 9,,D UHFRPELQDQWH KXPDQR VH FRQVLGHUD DFWXDOPHQWH HO WUDWDPLHQWR GH HOHFFLyQ HQORVSDFLHQWHVKHPRItOLFRVFRQLQKLELGRUHVGHDOWD UHVSXHVWDSRUTXHQRJHQHUDUHVSXHVWDDQDPQpVLFDGH ORVWtWXORVGHOLQKLELGRUFRQWUDHO)9,,,WLHQHPHQRU ULHVJRGHWURPERVLV\VHHYLWDHOULHVJRHPSOHDUXQ SURGXFWRGHRWUDHVSHFLHFRPRHQHOFRQFHQWUDGR GH IDFWRU 9,,, SRUFLQR 6LQ HPEUDJR XQR GH ORV PD\RUHVSUREOHPDVGHVXXVRHVVXDOWRFRVWR (QDOJXQRVSDtVHVVHKDHPSOHDGRHO)9,,,SRUFLQR SDUD HO SDFLHQWH FRQ DOWD UHVSXHVWD $XQTXH VH KD REVHUYDGR XQ PHQRU ULHVJR GH UHVSXHVWD DQDPQpVLFDGHORVWtWXORVGHDQWLFXHUSRVFRQWUDHO IDFWRU9,,,SRUFLQRGHEHUiYLJLODUVHODSRVLELOLGDG GHUHDFFLRQHVDQDÀOiFWLFDV 3ODVPDIHUHVLV /D SODVPDIHUHVLV HV XQ SURFHGLPLHQWR TXH HOLPLQD ORV LQKLELGRUHV GHO WRUUHQWHVDQJXtQHRGHXQDSHUVRQD*HQHUDOPHQWH VH XWLOL]D FXDQGR VH QHFHVLWD UHGXFLU UiSLGDPHQWH HO WtWXOR GHO LQKLELGRU SRU HMHPSOR DQWHV GH XQD FLUXJtDPD\RURHQFDVRVGHKHPRUUDJLDJUDYHTXH QRVRQELHQFRQWURODGRVFRQDJHQWHVGHGHVYtR 3DUD OD HUUDGLFDFLyQ GHO DQWLFXHUSR LQKLELWRULR OD LQPXQRVXSUHVLyQQRHVHÀFD]/DLQGXFFLyQGHOD WROHUDQFLDLQPXQROyJLFD,7,VHSUHVHQWDFRPR OD PHMRU RSFLyQ D ODUJR SOD]R SDUD SDFLHQWHV FRQ LQKLELGRUHV GH DOWD UHVSXHVWD (VWH SURFHGLPLHQWR GHVDUUROODGRHQVHEDVDHQODDGPLQLVWUDFLyQ GH GRVLV HOHYDGDV GH FRQFHQWUDQGR OLRÀOL]DGR GH )9,,, R GH FRPSOHMR SURWURPEtQLFR /D ,7, FRQVLVWH HQ DGPLQLVWUDU GRVLV IUHFXHQWHV GH FRQFHQWUDGRGHOIDFWRUDODSHUVRQDFRQLQKLELGRUHV GXUDQWHYDULRVPHVHVRDOJXQDVYHFHVDODxRDÀQ GH HQWUHQDU DO FXHUSR D UHFRQRFHU HO SURGXFWR GH WUDWDPLHQWR 'HVSXpV GH VHLV PHVHV D XQ DxR ORV WtWXORV GH DQWLFXHUSRV FRQWUD HO )9,,, VH UHGXFHQ FRQVLGHUDEOHPHQWHKDVWDOOHJDUDFHUR ([LVWHQ RWURV SURFHGLPLHQWRV SDUD OD WROHUDQFLD LQPXQROyJLFDFRPRHOHPSOHRGHODLQPXQRJOREXOLQD * OD LQPXQRDGVRUFLRQ LQPXQRVXSUHVLyQ FRQ FLFORIRVIDPLGD SUHGQLVRQD ERORV GH PHWLOSUHGQLVRORQD R OD FRPELQDFLyQ GH WRGRV HVWRV SURFHGLPLHQWRV $FWXDOPHQWH VH HVWi WUDEDMDQGR HQ HO WUDWDPLHQWR FRQ WHUDSLD JpQLFD TXH SHUPLWH OD FXUDFLyQGHODKHPRÀOLDPHGLDQWHODWUDQVIHUHQFLDGH PDWHULDO JHQpWLFR DO SDFLHQWH D WUDYpV GH GLIHUHQWHV PpWRGRVGHLQJHQLHUtDJHQpWLFD DISCUSIÓN /RV LQKLELGRUHV DSDUHFHQ FRQ XQD DOWD LQFLGHQFLD HQ SDFLHQWHV FRQ +HPRÀOLD $ FRQJpQLWD KDVWD XQ HQ SDFLHQWHV JUDYHV \ HQWUH HQ SDFLHQWHVPRGHUDGRV\OHYHV7LHQGHQDDSDUHFHU WUDVODVSULPHUDVDGPLQLVWUDFLRQHVGHFRQFHQWUDGR GH)9,,,ORFXDOVXHOHFRLQFLGLUFRQORVSULPHURV DxRV GH OD YLGD GHO SDFLHQWH $SUR[LPDGDPHQWH XQ GH ORV QLxRV FRQ KHPRÀOLD JUDYH TXH LQLFLDQWUDWDPLHQWRQRWROHUDQDOIDFWRUSHUIXQGLGR /RV PHFDQLVPRV SRU ORV FXDOHV XQ GH ORV KHPRItOLFRV WROHUDQ OD SURWHtQD SHUIXQGLGD FRQ HO WUDWDPLHQWR QR VRQ ELHQ FRQRFLGRV 'DWR FDUDFWHUtVWLFRGHELGRDTXHHOSDFLHQWHHQHVWXGLR GXUDQWH PXFKRV DxRV PRVWUy EXHQD UHVSXHVWD DO WUDWDPLHQWR FRQ )9,,, \ IXH KDVWD OD HGDG GH ORV DxRVTXHPRVWUyWROHUDQFLDDGLFKRWUDWDPLHQWR SRU OR TXH VH REVHUYD TXH ORV SDFLHQWHV SXHGHQ GHVDUUROODU LQKLELGRUHV HQ FXDOTXLHU HWDSD GH OD YLGD DXQTXH VHUtD GLItFLO LGHQWLÀFDU OD FDXVD GH SRUTXpHOVLVWHPDLQPXQHGHVSXpVGHWDQWRVDxRV GH WUDWDPLHQWR FRPHQ]y D UHDFFLRQDU \ DWDFDU HO )9,,,SURWHtQDTXHKDEtDVLGRELHQWROHUDGDGXUDQWH PXFKRVDxRV $FWXDOPHQWH HO GHVDUUROOR GH DQWLFXHUSRV LQKLELGRUHVFRQGLFLRQDQRVyORXQDGLVPLQXFLyQGH Rev. Fac. Cienc. Méd. Julio - Diciembre 2010 Inhibidores Contra el Factor VIII de Coagulación en la Hemofilia Tipo A ODFDOLGDGGHYLGDGHORVSDFLHQWHVVLQRTXHWDPELpQ WLHQHLPSRUWDQWHVFRQVHFXHQFLDVVRFLRHFRQyPLFDV GDGR HO LQFUHPHQWR HQ HO FRVWR GHO WUDWDPLHQWR (Q ORV SDtVHV ODWLQRDPHULFDQRV H[LVWHQ PXFKRV SUREOHPDV VRFLDOHV \ HFRQyPLFRV (Q PXFKRV GH HVWRVSDtVHVREWHQHUSURGXFWRVSDUDHOWUDWDPLHQWR GH ORV SDFLHQWHV FRQ LQKLELGRUHV GH )DFWRU 9,,, HQ OD KHPRÀOLD 7LSR$ QR KD VLGR XQD SULRULGDG UHVXOWDQGR HQ FDUHQFLD GH WUDWDPLHQWRV DGHFXDGRV \JHQHUDQGRHQHVWRVVHULDVFRQVHFXHQFLDV(Q +RQGXUDVVHFDUHFHQRVyORGHWUDWDPLHQWRDGHFXDGR VL QR DGHPiV GH PpWRGRV ORV GLDJQyVWLFRV SDUD LGHQWLÀFDUODVSHUVRQDVTXHKDQFUHDGRDQWLFXHUSRV FRQWUD)DFWRU9,,,HVWRHVGHELGRDORVDOWRVFRVWRV TXHUHSUHVHQWDQGLFKRVPDWHULDOHV3RUORTXHHVWRV SDFLHQWHV HVWiQ FRQGHQDGRV DO VXIULPLHQWR \ D SHUPDQHFHULQGHÀQLGDPHQWHKRVSLWDOL]DGRV /D OLPLWDFLyQ H[FOX\HQWH SDUD WUDWDU HÀFD]PHQWH XQ SDFLHQWH FRQ LQKLELGRU HV DFWXDOPHQWH OD VLWXDFLyQ HFRQyPLFD(VSRUHOORTXHHOWUDWDPLHQWRGHSDFLHQWHV FRQ LQKLELGRUHV GHEH UHDOL]DUVH HQIRFDQGR VX WHUDSpXWLFDGHDFXHUGRFRQODUHDOLGDGGHFDGDSDtV\ FRQHOHPSOHRUDFLRQDOGHVXVUHFXUVRVWHUDSpXWLFRV BIBLIOGRAFÍA $UUXGD 9 +LJK . 7UDVWRUQRV GH OD &RDJXODFLRQ,Q)DXFL$6.DVSHU'//RQJR '/ %UDXQZDOG ( +DXVHU 6/ -DPHVRQ -/ /RVFDO]R - +DUULVRQ 3ULQFLSLRV GH 0HGLFLQD ,QWHUQDHG0H[LFR0F*UDZ+LOO 3 $VWHU -& (QIHUPHGDGHV GH ORV +HPDWtHV \ 7UDVWRUQRV+HPRUUDJLFRV,Q.XPDU9$EEDV $. )DXVWR 1 5RELQ \ &RWUDQ 3DWRORJLD (VWXFWXUDO\)XQFLRQDOHG(VSDxD(OVHYLHU 3 )HGHUDFLyQ 0XQGLDO GH +HPRÀOLD 4XH VRQ ORV ,QKLELGRUHV >0RQRJUDItD HQ LQWHUQHW@ &DQDGi)HGHUDFLyQ0XQGLDO+HPRÀOLD >FRQVXOWDGR HO GH MXQLR @ 'LVSRQLEOH HQ KWWSZZZZIKRUJGRFV3XEOLFDWLRQV ,QKLELWRUV,QKLELWRUVBERRNOHWB63SGI /XQD*$5LYHUD3&$UHOODQR*-0HQGR]D *0iUTXH]-/*RQ]iOH]$$HWDO0HGLFLyQ GHODDFWLYLGDGGHIDFWRUHV9,,,\,;FRDJXODQWH \ VXV SRVLEOHV LQKLELGRUHV HQ XQD SREODFLyQ GH QLxRV KHPRItOLFRV %LRTXLPLD >5HYLVWD HQ ,QWHUQHW@ >&RQVXOWDGR HO GH PD\R @ VXSO $ 'LVSRQLEOH HQ KWWS UHGDO\FXDHPH[P[SGISGI $]QDU -$ 9LOODU $ ,QKLELGRUHV DQWL ),,, +DHPDWRORJLFD HG HVS >(Q OtQHD@ >&RQVXOWDGR HO GH PD\R @ VXSO 'LVSRQLEOH HQ KWWSZZZVHWKHV SRQHQFLDVVLPSRVLRVLQKLELGRUHVBDQWLB IYLLLSGI %LDQFR 53 2]HOR 0& 9LOODoD 35 6RODQR 0+&UX]*-0XULOOR&0HWDO'LDJQyVWLFR \ WUDWDPLHQWR GH OD KHPRÀOLD FRQJpQLWD FRQ LQKLELGRUHV 8Q FRQVHQVR ODWLQRDPHULFDQR >(Q OtQHD@ >&RQVXOWDGR GH PD\R @ 'LVSRQLEOHHQKWWSZZZDVKHFRYDRUJSKSB OLEDUFKLYRBGHVFDUJDUSKS"GRFBLG 2FKRD 0$ 'HWHFFLyQ GH ,QKLELGRUHV HQ SDFLHQWHV FRQ +HPRÀOLD +HUHGLWDULD >7HVLV HQ LQWHUQHW@ 0p[LFR 3URJUDPD GH (VSHFLDOLGDG HQ +HPDWRORJtD >&RQVXOWDGRHOGHPD\R@'LVSRQLEOH HQ KWWSLW]DPQDEQFWLSQP[ G V S D F H E L W V W UH D P '(7(&&,21,1+,%SGI 'L0LFKHOH '0 ,QKLELGRUHV HQ KHPRÀOLD LQIRUPDFLyQEiVLFD>0RQRJUDIuDHQ,QWHUQHW@ &DQDGi)HGHUDFLyQ0XQGLDOGHOD+HPRÀOLD >&RQVXOWDGR HO GH GLFLHPEUH @ 'LVSRQLEOH HQ KWWSZZZZIK RUJGRFV3XEOLFDWLRQV,QKLELWRUV72+B ,QKLELWRUVB63SGI $UDQGD + $YDQFHV HQ HO WUDWDPLHQWR GH OD KHPRÀOLD 5HY 0HG ,QVW 0H[ 6HJXUR 6RF >5HYLVWD HQ ,QWHUQHW@ >&RQVXOWDGR HO GH PD\R @ 6XSO 'LVSRQLEOH HQ KWWSQHZPHGLJUDSKLFFRP FJLELQUHVXPHQ0DLQFJL",'$57,&8/2 ,'38%/,&$&,21 ,'5(9,6 7$ Rev. Fac. Cienc. Méd. Julio - Diciembre 2010 Inhibidores Contra el Factor VIII de Coagulación en la Hemofilia Tipo A +DXVO & $KPDG 58 6DVJDU\ 0 'RHULQJ &% /ROODU 3 HW DO +LJKGRVH IDFWRU 9,,, LQKLELWV IDFWRU 9,,,VSHFLÀF PHPRU\ % FHOOV LQ KHPRSKLOLD $ ZLWK IDFWRU 9,,, LQKLELWRUV %ORRG>5HYLVWDHQ,QWHUQHW@>&RQVXOWDGR HO GH $EULO @ 'LVSRQLEOH HQ KWWSZZZQFELQOPQLKJRY SXEPHG 3HHUOLQFN . -DFTXHPLQ 0* $UQRXW - +R\ODHUWV 0) *LOOHV -* /DYHQG·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ev. Fac. Cienc. Méd. Julio - Diciembre 2010